To cite this paper use one of the standards below:
Background: Glioblastoma (GB) is the most frequent and lethal primary brain tumor, displaying rapid growth and spreading to surrounding healthy tissues. The standard therapy for GB consists of surgery followed by combined radiotherapy, but it fail to cure GB patients. Asthma and allergy have an inverse association with GB, and eosinophilia is associated with a better outcome and increased patient survival. Human GB release large quantities of cysteinyl-leukotrienes and GM-CSF. Both factors activate eosinophils, inducing eosinopoiesis, protein expression, degranulation, and migration. Eosinophils releases various cytotoxic factors that act on tumor cells inducing cell death. Previously we described an in vitro interaction between GB cells and eosinophils, where GB cells recruits eosinophils through GM-CSF signaling, and these eosinophils suppress metabolism, migration, and proliferation, inducing apoptosis in vitro. Methods: Here, we isolated GB cells and injected in the brain of Swiss Webster mice. The brain was collected for histological imaging. The role of infiltrating eosinophils in the tumor mass was assessed by immunofluorescence to evaluate the induction of GB cell apoptosis (Casp-3), reduction in cell proliferation (ki-67), expression of cytotoxic molecules by eosinophils (FasL, eosinophil peroxidase), and other relevant molecules. Results: We obtained tissue from mice that spontaneously developed eosinophilia, accessed by blood smear counts. The presence of eosinophils in the brain tumor mass showed decreased VEGF-, phosphorilated TAU protein-, and KI-67-positive cells, and higher production of HIF-1a, SOX-2, and cleaved caspase 3-positive cells, compared to mice without eosinophilia. Conclusion: The alterations in the GB mass by the local eosinophils suggests lesser angiogenic and migration potential, hindered glioma stem cell formation, and tumor suppression, which could lead to lower metastasis and increased overall survival and prognosis.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper